Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity

Journal of Microencapsulation

Volumn 25, Issue 6, 2008, Pages 421-425

  Dass, Crispin R ^a   Friedhuber, Anna M ^a   Khachigian, Levon M ^b   Dunstan, Dave M ^a   Choong, Peter F M ^a,c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Apoptosis; Bone; C jun; Cancer; Chitosan; Deoxyribozyme; Nanoparticle

Indexed keywords

CHITOSAN; DZ13 PROTEIN; NANOPARTICLE; OLIGONUCLEOTIDE; PLACEBO; PROTEIN C JUN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; GENE EXPRESSION; MOUSE; NANOBIOTECHNOLOGY; NONHUMAN; OSTEOSARCOMA; ROOM TEMPERATURE; SLOW RELEASE FORMULATION;

ANIMALS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; BIOTECHNOLOGY; BONE AND BONES; CHITOSAN; DNA, CATALYTIC; DRUG DELIVERY SYSTEMS; MICE; MICE, INBRED BALB C; NANOPARTICLES; NANOTECHNOLOGY; OSTEOSARCOMA; PLACEBOS; PROTO-ONCOGENE PROTEINS C-JUN;

EID: 49049099445     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040802033673     Document Type: Article

References (14)

1. Alivisatos, AP, Johnsson, KP, Peng, X., Wilson, TE, Loweth, CJ, Bruche, Jr MP and Schultz, PG (1996) Organization of 'nanocrystal molecules' using DNA. Nature, 382, pp. 609-611.
2. Dass, CR, Contreras, KG, Dunstan, DE and Choong, PF (2007) Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. Biomaterials, 28, pp. 3026-3033.
3. Dass, CR, Ek, ET, Contreras, KG and Choong, PF (2006) A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin Exp Metastasis, 23, pp. 367-380.
4. Dass, CR, Saravolac, EG, Li, Y. and Sun, LQ (2002) Cellular uptake, distribution, and stability of 10-23 deoxyribozymes. Antisense Nucl Acid Drug Dev, 12, pp. 289-299.
5. Fahmy, R., Waldman, A., Zhang, G., Mitchell, A., Tedla, N., Cai, H., Chesterman, CN, Geczy, CR, Perry, MA and Khachigian, LM (2006) Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun. Nature Biotech, 24, pp. 856-863.
6. Franchi, A., Calzolari, A. and Zampi, G. (1998) Immunohistochemical detection of c-fos and c-jun expression in osseous and cartilaginous tumours of the skeleton. Virchows Arch, 432, pp. 515-519.
7. Habraken, WJ, Wolke, JG and Jansen, JA (2007) Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev, 59, pp. 234-248.
8. Isaka, Y. (2007) DNAzymes as potential therapeutic molecules. Curr Opin Mol Ther, 9, pp. 132-136.
9. Longhi, A., Errani, C., De Paolis, M., Mercuri, M. and Bacci, G. (2006) Primary bone osteosarcoma in the pediatric age: State of the art. Cancer Treat Rev, 32, pp. 423-436.
10. Mirkin, CA, Letsinger, RL, Mucic, RC and Storhoff, JJ (1996) A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature, 382, pp. 607-609.
11. Papachristou, DJ, Batistatou, A., Sykiotis, GP, Varakis, I. and Papavassiliou, AG (2003) Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone, 32, pp. 364-371.
12. Roy, K., Mao, HQ, Huang, SK and Leong, KW (1999) Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med, 5, pp. 387-391.
13. Santoro, SW and Joyce, GF (1997) A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA, 94, pp. 4262-4266.
14. Zhang, G., Dass, CR, Sumithran, E., Di Girolamo, N, Sun, LQ and Khachigian, LM (2004) Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. J Natl Cancer Inst, 96, pp. 683-696.